Global supplier of life science reagents and services from the UK seeks novel research grade products and technology under manufacturing and license agreements

Summary

A UK based global supplier of reagents and services for the life science research markets is seeking new partners under manufacturing and license agreements for the supply of novel reagents, such as proteins, antibodies and small molecules to complement its existing catalogue and development of new products and services. Reagents and services for proteomic analysis in the following areas are of interest: cancer, stem cells, neuroscience, immunology and cardiovascular disease.

Description

The UK company has developed a large portfolio and catalogue of Research Use Only (RUO) antibodies, proteins, small molecules and ELISA kits for proteomic applications across a broad range of key biological research areas including cancer, stem cells, neuroscience and immunology. The company supplies both the academic and industry life science & biotech markets through both B2C and B2B channels. The company is continually looking to expand its existing portfolio of products and services by partnering and inward licensing with academic and research partners.
The company offers partners the benefits of a major, recognisable brand name under which products are sold worldwide through a well established distributor network. It also offers in-house expertise for the development of in-licensed new products and services into ELISA kits and derivative products such as antibody conjugates, providing greater opportunities to generate revenue.
The company is seeking researchers and/or developers to license in new products that the company would develop to be market-ready.
Manufacturers of described products are sought to manufacture them and supply for selling from the UK, under manufacturing agreements.

Technical Specification or Expertise Sought

The company is seeking partners with published and developed high quality research products and/or related technologies that will improve the company’s product portfolio in the research areas of: • Cancer • Cell Biology • Neuroscience • Cell Signalling • Inflammation • Stem Cell Biology Interested partners are asked to send a catalogue of products and complementary data or outline of services offered for assessment.

Stage of development

Already on the market

Contact/ source: Enterprise Europe Network (europa.eu)